Annual Current Liabilities
$28.41 M
-$53.64 M-65.38%
December 31, 2024
Summary
- As of March 12, 2025, AMLX annual total current liabilities is $28.41 million, with the most recent change of -$53.64 million (-65.38%) on December 31, 2024.
- During the last 3 years, AMLX annual current liabilities has risen by +$11.01 million (+63.29%).
- AMLX annual current liabilities is now -65.38% below its all-time high of $82.04 million, reached on December 31, 2023.
Performance
AMLX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$28.41 M
-$25.51 M-47.31%
December 31, 2024
Summary
- As of March 12, 2025, AMLX quarterly total current liabilities is $28.41 million, with the most recent change of -$25.51 million (-47.31%) on December 31, 2024.
- Over the past year, AMLX quarterly current liabilities has dropped by -$53.64 million (-65.38%).
- AMLX quarterly current liabilities is now -69.00% below its all-time high of $91.64 million, reached on March 31, 2024.
Performance
AMLX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
AMLX Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -65.4% | -65.4% |
| 3 y3 years | +63.3% | -37.7% |
| 5 y5 years | +527.2% | -37.7% |
AMLX Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -65.4% | +63.3% | -69.0% | +63.3% |
| 5 y | 5-year | -65.4% | +527.2% | -69.0% | +287.7% |
| alltime | all time | -65.4% | +527.2% | -69.0% | +287.7% |
Amylyx Pharmaceuticals Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $28.41 M(-65.4%) | $28.41 M(-47.3%) |
| Sep 2024 | - | $53.91 M(-23.1%) |
| Jun 2024 | - | $70.08 M(-23.5%) |
| Mar 2024 | - | $91.64 M(+11.7%) |
| Dec 2023 | $82.04 M(+76.0%) | $82.04 M(+79.8%) |
| Sep 2023 | - | $45.62 M(-28.8%) |
| Jun 2023 | - | $64.08 M(+24.2%) |
| Mar 2023 | - | $51.62 M(+10.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $46.61 M(+167.9%) | $46.61 M(+42.8%) |
| Sep 2022 | - | $32.65 M(+20.2%) |
| Jun 2022 | - | $27.16 M(-2.0%) |
| Mar 2022 | - | $27.71 M(+59.3%) |
| Dec 2021 | $17.40 M(+137.5%) | $17.40 M(+14.9%) |
| Sep 2021 | - | $15.15 M(+106.7%) |
| Dec 2020 | $7.33 M(+61.8%) | $7.33 M |
| Dec 2019 | $4.53 M | - |
FAQ
- What is Amylyx Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Amylyx Pharmaceuticals?
- What is Amylyx Pharmaceuticals annual current liabilities year-on-year change?
- What is Amylyx Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Amylyx Pharmaceuticals?
- What is Amylyx Pharmaceuticals quarterly current liabilities year-on-year change?
What is Amylyx Pharmaceuticals annual total current liabilities?
The current annual current liabilities of AMLX is $28.41 M
What is the all time high annual current liabilities for Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals all-time high annual total current liabilities is $82.04 M
What is Amylyx Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, AMLX annual total current liabilities has changed by -$53.64 M (-65.38%)
What is Amylyx Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of AMLX is $28.41 M
What is the all time high quarterly current liabilities for Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals all-time high quarterly total current liabilities is $91.64 M
What is Amylyx Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, AMLX quarterly total current liabilities has changed by -$53.64 M (-65.38%)